Description
Our session intends to share information with an audience interested in starting anti-obesity medication programs in their surgical practice.
Learning Objectives
- Educate the audience on the commonly used anti-obesity medications used by bariatric surgeons.
- Educate the audience on the benefits and utility of an anti-obesity pharmaceutical program within a bariatric surgical practice.
- Educate the audience on some of the pitfalls associated with off-label usage of certain medications and some of the hazards of using non-FDA-approved compounded medicines for weight loss.
- Educate the audience on the future relationship between AOM and the growth of our subspecialty.
10:15am |
Introduction John Scott, MD |
10:20am |
A Primer for AOM use in a Surgery Practice Alice Wang, MD MHS |
10:35am |
Maintaining Medical Management Program within a Surgical Practice Peter S Billing, MD FASMBS |
10:50am |
Perioperative Management of AOMs Sarah Samreen, MD |
11:05am |
Pitfalls of Off-label Medications and Compounding pharmacies R. Wesley Vosburg, MD FACS FASMBS |
Debate: AOMs are Critical to the Future of Bariatric Surgery vs AOMs are Detrimental to Future Surgical Practice |
|
11:20am |
Debate: AOMs are Critical to the Future of Bariatric Surgery (PRO) vs AOMs are Detrimental to Future Surgical Practice (CON) Rami Lutfi, MD FACS FASMBS; L. Renee Hilton-Rowe, MD; Colleen I Kennedy, FASMBS MBA MD |
11:45am |
Question/Answer Session with Speakers Panel Karina McArthur, MD |
12:00pm | Adjourn |